The market is segmented based on , By Product Type (Transplant Diagnostic Instrument, Transplant Diagnostic Software, Transplant Diagnostic Reagent), Technology (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays), Transplant Type (Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation, Bone Marrow Transplantation, Other Transplants), Application (Diagnostic Applications, Research Applications), End User (Research Laboratories and Academic Institutes, Hospital and Transplant Centers, Commercial Service Providers, Others), Distribution Channel (Direct Tender, Retail Sales, Others) Industry Trends and Forecast to 2029.
.
The North America Transplant Diagnostics Market size was valued at USD 0.00 USD Billion in 2021.
The North America Transplant Diagnostics Market is projected to grow at a CAGR of 6.9% during the forecast period of 2022 to 2029.
The major players operating in the market include Hologic , Biofortuna Limited, Takara Bio , Abbott Diagnostica, and more .
The market report covers data from the U.S., Canada, and Mexico.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.